The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2024
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Sdobnikova S.V.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Mirzabekova K.A.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Surguch V.K.

FGBU "NII glaznykh bolezneĭ RAMN"

Current approach and the role of laser photocoagulation in the treatment of retinal vein occlusions

Authors:

Sdobnikova S.V., Mirzabekova K.A., Surguch V.K.

More about the authors

Journal: Russian Annals of Ophthalmology. 2017;133(3): 67‑74

DOI: 10.17116/oftalma2017133367-74

Views: 4033

Downloaded: 155

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Sdobnikova SV, Mirzabekova KA, Surguch VK. Current approach and the role of laser photocoagulation in the treatment of retinal vein occlusions. Russian Annals of Ophthalmology. 2017;133(3):67‑74. (In Russ.)
https://doi.org/10.17116/oftalma2017133367-74

Подписка 2025 (Russian Annals of Ophthalmology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata

Despite the emergence of new approaches in the treatment of retinal vein thrombosis and post-thrombotic complications, namely, intravitreal pharmacotherapy and surgical treatment, laser photocoagulation continues to play a significant role in the management of patients with this pathology. Although the method of laser photocoagulation has been used for quite a long time, different views exist on its indications and execution in specific clinical situations. At that, not all opinions regarding the use of laser photocoagulation in thrombosis are based on convincing clinical studies. The aim of this work was to summarize current literature data on the use of laser photocoagulation in the integrated treatment of retinal vein occlusions and, also, to show which aspects of the treatment of thromboses can be considered well-established and reasonable and which remain a subject of debate.

Keywords:

retinal vein occlusions
central retinal vein thrombosis
laser photocoagulation

Authors:

Sdobnikova S.V.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Mirzabekova K.A.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Surguch V.K.

FGBU "NII glaznykh bolezneĭ RAMN"

List of references:

  1. Tultseva SN, Astakhov YS. Okklyuzii ven setchatki. [Retinal veins occlusion]. Saint Petersburg: «Publishers N-L»; 2010. (In Russ.)
  2. Karia N. Retinal vein occlusion: pathophysiology and treatment options. OPTH. 2010:809. https://doi.org/10.2147/opth.s7631
  3. Rogers S, McIntosh R, Lim L et al. Natural History of Branch Retinal Vein Occlusion: An Evidence-Based Systematic Review. Ophthalmology. 2010;117(6):1094-1101.e5. https://doi.org/10.1016/j.ophtha.2010.01.058
  4. Katsnelson LA, Phorophonova TI, Bunin AY. Sosudistye zabolevaniya glaz. [Ocular vascular diseases]. Moscow: «Medicine»; 1990. (In Russ.)
  5. Tankovskiy VE. Trombozy ven setchatki. [Retinal vein thrombosis]. Moscow; 2000. (In Russ.)
  6. Bynoe L, Hutchins R, Lazarus H, Friedberg M. Retinal Endovascular Surgery For Central Retinal Vein Occlusion. Retina. 2005;25(5):625-632. https://doi.org/10.1097/00006982-200507000-00014
  7. Sosnovskiĭ VV, Sdobnikova SV. Use of thrombolytic agents during invasive treatments for retinal vascular occlusions. Vestnik oftal’mologii. 2007;123(5): 51-54. (In Russ.)
  8. Sosnovskiĭ VV, Sdobnikova SV, Revishchin AV, Surguch VK, Troitskaia NA, Sidamonidze AL, Belogurov AA, Del’ver EP, Gurskiĭ IaG. Surgical treatment policy using recombinant prourokinase for submacular hemorrhages. Vestnik oftal’mologii. 2009; 125(4):3-8. (In Russ.)
  9. McAllister I, Vijayasekaran S, YuD. Intravitreal Tenecteplase (Metalyse) for Acute Management of Retinal Vein Occlusions. Investigative Opthalmology & Visual Science. 2013;54(7):4910. https://doi.org/10.1167/iovs.13-11967
  10. Mahmoud T, Peng Y, Proia A, Davidson M, Deramo V, Fekrat S. Recombinant tissue plasminogen activator injected into the vitreous cavity may penetrate the retinal veins of a porcine model of vascular occlusion. British Journal of Ophthalmology. 2006;90(7):911-915. https://doi.org/10.1136/bjo.2005.089037
  11. Kamei M, Matsumura N, Suzuki M, Sakimoto S, Sakaguchi H, Nishida K. Reperfusion of Large Ischemic Areas Associated With Central Retinal Vein Occlusion. JAMA Ophthalmol. 2014;132(3):361. https://doi.org/10.1001/jamaophthalmol.2013.6334
  12. Elman M, Raden R, Carrigan A. Intravitreal Injection of Tissue Plasminogen Activator for Central Retinal Vein Occlusion. Retina. 2003;23(3):435. https://doi.org/10.1097/00006982-200306000-00045
  13. Shahid H. The management of retinal vein occlusion: is interventional ophthalmology the way forward?. British Journal of Ophthalmology. 2006;90(5):627-639. https://doi.org/10.1136/bjo.2005.068668
  14. Lazo-Langner A, Hawel J, Ageno W, Kovacs M. Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trials. Haematologica. 2010;95(9):1587-1593. https://doi.org/10.3324/haematol.2010.023614
  15. Donati G1, Mavrakanas N, Pournaras CJ. Isovolumic hemodilution in the management of the acute phase of central retinal vein occlusion: a pilot study. J Fr Ophtalmol. 2009;32(10):750-756. https://doi.org/ 10.1016/j.jfo.2009.10.010
  16. Hayreh S, Podhajsky P, Zimmerman M. Natural History of Visual Outcome in Central Retinal Vein Occlusion. Ophthalmology. 2011;118(1):119-133.e2. https://doi.org/10.1016/j.ophtha.2010.04.019
  17. A Randomized Clinical Trial of Early Panretinal Photocoagulation for Ischermic Central Vein Occlusion. Ophthalmology. 1995;102(10):1434-1444. https://doi.org/10.1016/s0161-6420(95)30848-2
  18. Natural History and Clinical Management of Central Retinal Vein Occlusion. Archives of Ophthalmology. 1997;115(4):486. https://doi.org/10.1001/archopht.1997.01100150488006
  19. Coscas G, Loewenstein A, Augustin A et al. Management of Retinal Vein Occlusion — Consensus Document. Ophthalmologica. 2011;226(1):4-28. https://doi.org/10.1159/000327391
  20. Hayreh S, Zimmerman M. Ocular Neovascularization Associated With Central And Hemicentral Retinal Vein Occlusion. Retina. 2012;32(8):1553-1565. https://doi.org/10.1097/iae.0b013e318246912c
  21. Lattanzio R, Torres Gimeno A, Battaglia Parodi M, Bandello F. Retinal Vein Occlusion: Current Treatment. Ophthalmologica. 2011;225(3):135-143. https://doi.org/10.1159/000314718
  22. Chan C, Ip M, Vanveldhuisen P et al. SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion. Ophthalmology. 2011;118(7):1364-1372. https://doi.org/ 10.1016/j.ophtha.2010.11.020
  23. Hayreh S, Rojas P, Podhajsky P, Montague P, Woolson R. Ocular Neovascularization with Retinal Vascular Occlusion-III. Ophthalmology. 1983;90(5):488-506. https://doi.org/10.1016/s0161-6420(83)34542-5
  24. Kansky DD, Milevsky SA, D’Amato BE, Tanner B. Zabolevaniya glaznogo dna. [Diseases of ocular fundus]. Moscow: Medpress-inform; 2009. (In Russ.)
  25. A Randomized Clinical Trial of Early Panretinal Photocoagulation for Ischermic Central Vein Occlusion. Ophthalmology. 1995;102(10):1434-1444. https://doi.org/10.1016/s0161-6420(95)30848-2
  26. Argon Laser Scatter Photocoagulation for Prevention of Neovascularization and Vitreous Hemorrhage in Branch Vein Occlusion. Archives of Ophthalmology. 1986;104(1):34. https://doi.org/10.1001/archopht.1986.01050130044017
  27. Argon Laser Photocoagulation for Macular Edema in Branch Vein Occlusion. American Journal of Ophthalmology. 1984;98(3):271-282. https://doi.org/10.1016/0002-9394(84)90316-7
  28. Early Photocoagulation for Diabetic Retinopathy. Ophthalmology. 1991; 98(5):766-785. https://doi.org/10.1016/s0161-6420(13)38011-7
  29. Bandello F, Brancato R, Trabuccbi G, Lattanzio R, Malegori A. Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy: A randomized study in 44 eyes with a long follow-up time. Graefe’s Arch Clin Exp Ophthalmol. 1993;231(9):491-494. https://doi.org/10.1007/bf00921112
  30. Bandello F, Brancato R, Lattanzio R, Trabucchi G, Azzolini C, Malegori A. Double frequency Nd:YAG laser vs. argon green laser in the treatment of proliferative diabetic retinopathy: Randomized study with long term follow up. Lasers Surg Med. 1996;19(2):173-176. https://doi.org/10.1002/(sici)1096-9101(1996)19:2<173::aid-lsm8>3.3.co;2-c
  31. Macarie S, Macarie D. Efficacity of diode laser photocoagulation in retinal neovascularization treatment in diabetic retinopathy. Oftalmologia. 2002;53(2):89-92.
  32. The Royal College of Ophthalmology Retinal Vein Occlusion (RVO) Guidelines 2015. https://www.rcophth.ac.uk/wp-content/uploads/2015/07/Retinal-Vein-Occlusion-RVO-Guidelines-July-2015.pdf
  33. Rehak M, Tilgner E, Franke A, Rauscher F, Brosteanu O, Wiedemann P. Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study). Graefes Arch Clin Exp Ophthalmol. 2013;252(5):745-752. https://doi.org/10.1007/s00417-013-2528-8
  34. Spaide R. Рrospective study of peripheral panretinal photocoagulation of areas of nonperfusion in central retinal vein occlusion. Retina. 2013;33(1):56-62. https://doi.org/10.1097/iae.0b013e3182641875
  35. Michels R, Gass J. Тhe natural course of retinal branch vein obstruction. Retina. 1991;11(1):12-23. https://doi.org/10.1097/00006982-199111010-00003
  36. McIntosh R, Rogers S, Lim L et al. Natural History of Central Retinal Vein Occlusion: An Evidence-Based Systematic Review. Ophthalmology. 2010;117(6):1113-1123.e15. https://doi.org/10.1016/j.ophtha.2010.01.060
  37. Bloom S. Laser Surgery Of The Posterior Segment. Philadelphia: Lippincott; 1991.
  38. Akduman L, Olk R. Diode Laser (810 nm) versus Argon Green (514 nm) Modified Grid Photocoagulation for Diffuse Diabetic Macular Edema. Ophthalmology. 1997;104(9):1433-1441. https://doi.org/10.1016/s0161-6420(97)30119-5
  39. Browning D, Antoszyk A. The effect of the surgeon and the laser wavelength on the response to focal photocoagulation for diabetic macular edema. Ophthalmology. 1999;106(2):243-248. https://doi.org/10.1016/s0161-6420(99)90063-5
  40. Saeed M, Parmar D, McHugh D. Frequency-doubled Nd:YAG laser for the treatment of exudative diabetic maculopathy. Eye. 2001;15(6):712-718. https://doi.org/10.1038/eye.2001.235
  41. Lee CM, Olk RJ, Akduman L. Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy. Ophthalmic Surg Lasers. 2000;31(4):292-300.
  42. Parodi M, Spasse S, Iacono P, Di Stefano G, Canziani T, Ravalico G. Subthreshold Grid Laser Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion with Micropulse Infrared (810 Nanometer) Diode Laser. Ophthalmology. 2006;113(12):2237-2242. https://doi.org/10.1016/j.ophtha.2006.05.056
  43. Akduman L, Olk RJ. Subthresold (invisible) modified grid diode laser photocoagulation in diffuse diabetic macular edema. Ophthalmic Surg Lasers. 1999;9:706-714.
  44. Brown DM, Heier JS, Clark WL, Boyer DS, Vitti R, Berliner AJ, Zeitz O, Sandbrink R, Zhu X, Haller JA. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. Am J Ophthalmol. 2013;155(3):429-437.e7. https://doi.org/ 10.1016/j.ajo.2012.09.026
  45. Varma R, Bressler N, Suñer I et al. Improved Vision-Related Function after Ranibizumab for Macular Edema after Retinal Vein Occlusion. Ophthalmology. 2012;119(10):2108-2118. https://doi.org/10.1016/j.ophtha.2012.05.017
  46. Epstein D, Algvere P, von Wendt G, Seregard S, Kvanta A. Benefit from Bevacizumab for Macular Edema in Central Retinal Vein Occlusion: Twelve-Month Results of a Prospective, Randomized Study. Ophthalmology. 2012;119(12):2587-2591. https://doi.org/10.1016/j.ophtha.2012.06.037
  47. Wroblewski J, Wells J, Adamis A et al. Pegaptanib Sodium for Macular Edema Secondary to Central Retinal Vein Occlusion. Archives of Ophthalmology. 2009;127(4):374-80. https://doi.org/10.1001/archophthalmol.2009.14
  48. Shah N, Shah U. Long-term effect of early intervention with single intravitreal injection of bevacizumab followed by panretinal and macular grid photocoagulation in central retinal vein occlusion (CRVO) with macular edema: A pilot study. Eye. 2011;25(2):239-244. https://doi.org/10.1038/eye.2010.225
  49. Donati S, Barosi P, Bianchi M, Al Oum M, Azzolini C. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion. EJO. 2011;22(4):607-614. https://doi.org/10.5301/ejo.5000085
  50. Algvere P, Epstein D, von Wendt G, Seregard S, Kvanta A. Intravitreal bevacizumab in central retinal vein occlusion: 18-month results of a prospective clinical trial. EJO. 2011;21(6):789-795. https://doi.org/10.5301/ejo.2011.6522
  51. Funk M, Kriechbaum K, Prager F et al. Intraocular Concentrations of Growth Factors and Cytokines in Retinal Vein Occlusion and the Effect of Therapy with Bevacizumab. Investigative Opthalmology & Visual Science. 2009;50(3):1025. https://doi.org/10.1167/iovs.08-2510
  52. Stahl A, Struebin I, Hansen L, et al. Bevacizumab in central retinal vein occlusion: a retrospective analysis after 2 years of treatment. European Journal of Ophthalmology. 2010;20(1):180-185.
  53. Campochiaro P, Heier J, Feiner L et al. Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion. Ophthalmology. 2010;117(6):1102-1112.e1. https://doi.org/10.1016/j.ophtha.2010.02.021
  54. Brown DM. Clinical implications of the BRAVO and CRUISE trials. Retina Today. 2010;5:38-40.
  55. Haller J, Dugel P, Weinberg D, Chou C, Whitcup S. Evaluation Of The Safety And Performance Of An Applicator For A Novel Intravitreal Dexamethasone Drug Delivery System For The Treatment Of Macular Edema. Retina. 2009;29(1):46-51. https://doi.org/10.1097/iae.0b013e318188c814
  56. Scott I, VanVeldhuisen P, Oden N et al. SCORE Study Report 1: Baseline Associations between Central Retinal Thickness and Visual Acuity in Patients with Retinal Vein Occlusion. Ophthalmology. 2009;116(3):504-512. https://doi.org/10.1016/j.ophtha.2008.10.017
  57. Haller J, Bandello F, Belfort R et al. Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion. Ophthalmology. 2010;117(6):1134-1146.e3. https://doi.org/10.1016/j.ophtha.2010.03.032
  58. Moraczewski A, Lee R, Palmberg P, Rosenfeld P, Feuer W. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. British Journal of Ophthalmology. 2008;93(5):589-593. https://doi.org/10.1136/bjo.2008.151472
  59. Kofoed P, Munch I, Larsen M. Profound retinal ischaemia after ranibizumab administration in an eye with ocular ischaemic syndrome. Acta Ophthalmologica. 2009;88(7):808-810. https://doi.org/10.1111/j.1755-3768.2009.01612.x
  60. Quaggin S. Turning a blind eye to anti-VEGF toxicities. Journal of Clinical Investigation. 2012;122(11):3849-3851. https://doi.org/10.1172/jci65509
  61. Dınc E, Yıldırım O, Necat Yılmaz S et al. Intravitreal bevacizumab effects on VEGF levels in distant organs: an experimental study. Cutaneous and Ocular Toxicology. 2013;33(4):275-282. https://doi.org/10.3109/15569527.2013.855227
  62. Matsuyama K, Ogata N, Matsuoka M, Wada M, Takahashi K, Nishimura T. Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab. British Journal of Ophthalmology. 2010;94(9):1215-1218. https://doi.org/10.1136/bjo.2008.156810
  63. Papadopoulou D, Mendrinos E, Mangioris G, Donati G, Pournaras C. Intravitreal Ranibizumab May Induce Retinal Arteriolar Vasoconstriction in Patients with Neovascular Age-related Macular Degeneration. Ophthalmology. 2009;116(9):1755-1761. https://doi.org/10.1016/j.ophtha.2009.03.017
  64. Mete A, SaygiÌ O, Mete A, Bayram M, BekiÌ N. Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration. J Clin Ultrasound. 2009:NA-NA. https://doi.org/10.1002/jcu.20650
  65. Nishijima K, Ng Y, Zhong L et al. Vascular Endothelial Growth Factor-A Is a Survival Factor for Retinal Neurons and a Critical Neuroprotectant during the Adaptive Response to Ischemic Injury. The American Journal of Pathology. 2007;171(1):53-67. https://doi.org/10.2353/ajpath.2007.061237
  66. Adelman R, Parnes A, Michalewska Z, Parolini B, Boscher C, Ducournau D. Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study. BioMed Research International. 2015;2015:1-9. https://doi.org/10.1155/2015/352487
  67. Park D, Kim I. Long-Term Effects Of Vitrectomy And Internal Limiting Membrane Peeling For Macular Edema Secondary To Central Retinal Vein Occlusion And Hemiretinal Vein Occlusion. Retina. 2010;30(1):117-124. https://doi.org/10.1097/Iae.0b013e3181bced68
  68. Raszewska-Steglinska M, Gozdek P, Cisiecki S, Michalewska Z, Michalewski J, Nawrocki J. Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol. 2009; 19(6):1055-1062.
  69. Kumagai K, Furukawa M, Ogino N, Larson E, Uemura A. Long-Term Visual Outcomes After Vitrectomy For Macular Edema With Foveal Hemorrhage In Branch Retinal Vein Occlusion. Retina. 2007;27(5):584-588. https://doi.org/10.1097/01.iae.0000249576.98520.25
  70. DeCroos F, Shuler R, Stinnett S, Fekrat S. Pars Plana Vitrectomy, Internal Limiting Membrane Peeling, and Panretinal Endophotocoagulation for Macular Edema Secondary to Central Retinal Vein Occlusion. American Journal of Ophthalmology. 2009;147(4):627-633.e1. https://doi.org/10.1016/j.ajo.2008.10.024
  71. Arai M, Yamamoto S, Mitamura Y, Sato E, Sugawara T, Mizunoya S. Efficacy of Vitrectomy and Internal Limiting Membrane Removal for Macular Edema Associated with Branch Retinal Vein Occlusion. Ophthalmologica. 2009;223(3):172-176. https://doi.org/10.1159/000197113

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.